Recombinant Human BCA-1 (CXCL13)

Catalog No : IGX-RP458
3508.60€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Recombinant Human BCA-1 (CXCL13)
Catalog No IGX-RP458
Supplier’s Catalog No IGX-RP458
Supplier ImuGeX
Source antigen E. coli
Reactivity Human
Cross reactivity
Applications
Molecular weight 10
Storage -70°C
Other names BLC, B cell Attracting Chemokine-1, CXCL13, C-X-C motif chemokine 13, BCA1
Grade Highly Purified
Purity >95% as determined by SDS-PAGE
Form Recombinant BCA-1 was lyophilized from a 0.2 μm filtered 20 mM PB,100 mM NaCl solution pH 7.5.
Reactivity life 6 months
Note For reserch purpose only
Purity >95% as determined by SDS-PAGE
Description The homeostatic chemokine CXCL13 is constitutively expressed in secondary lymphoid tissue and initiates lymphoid neogenesis when expressed aberrantly in mice. CXCL13 has also been detected in chronic inflammation associated with human lymphoid neogenesis, suggesting a pathogenic role. Follicular dendritic cells (FDCs) are generally considered to be the major source of CXCL13 both in normal and aberrant lymphoid tissue. CXCL13 has been the exclusive ligand for CXCR5, which initiates chemotaxis toward an increasing gradient in vitro and to B cell zones in lymph nodes that express CXCL13. More recently, CXCR5 expression has also been shown in DN T cells in mice, a subset of CD4 follicular Th cells, and some tonsillar CD4+ and CD25+ Tregs in humans.